Systematic Review
. 2010 Apr; 28(17):2914-24.
doi: 10.1200/JCO.2009.25.8723.

Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review

Gary H Lyman 1 David C Dale  Debra A Wolff  Eva Culakova  Marek S Poniewierski  Nicole M Kuderer  Jeffrey Crawford  
Affiliations
  • PMID: 20385991
  •     43 citations

Abstract

Purpose: To evaluate the risk of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) and overall mortality in patients receiving chemotherapy with or without granulocyte colony-stimulating factor (G-CSF), a systematic review of randomized controlled trials (RCTs) was conducted.

Methods: Electronic databases searched through October 2008 identified 3,794 articles for initial screening. Eligibility included solid tumor or lymphoma patients randomly assigned to chemotherapy with or without G-CSF support, > or = 2 years of follow-up, and reporting AML/MDS or all second malignancies. Dual blinded data extraction was performed. Relative risk (RR) and absolute risk (AR) estimates +/- 95% CIs were calculated by the Mantel-Haenszel method.

Results: In the 25 eligible RCTs, 6,058 and 6,746 patients were randomly assigned to receive chemotherapy with and without initial G-CSF support, respectively. At mean and median follow-up across studies of 60 and 53 months, respectively, AML/MDS was reported in 22 control patients and 43 G-CSF-treated patients, with an estimated RR of 1.92 (95% CI, 1.19 to 3.07; P = .007) and AR increase of 0.41% (95% CI, 0.10% to 0.72%; P = .009). Deaths were reported in 1,845 patients randomly assigned to G-CSF and in 2,099 controls, for estimates of RR and AR decrease of 0.897 (95% CI, 0.857 to 0.938; P < .001) and 3.40% (95% CI, 2.01% to 4.80%; P < .001), respectively. Greater RR reduction for mortality was seen for both larger studies (P = .05) and greater chemotherapy dose-intensity (P = .012).

Conclusion: Delivered chemotherapy dose-intensity and risk of AML/MDS are increased but all-cause mortality is decreased in patients receiving chemotherapy with G-CSF support. Greater reductions in mortality were observed with greater chemotherapy dose-intensity.

Therapy-related myeloid neoplasms: pathobiology and clinical characteristics.
H Sill, W Olipitz, +2 authors, A Wölfler.
Br J Pharmacol, 2010 Nov 03; 162(4). PMID: 21039422    Free PMC article.
Review.
Treatment of cancer in the older aged person.
Lodovico Balducci.
Mediterr J Hematol Infect Dis, 2010 Jan 01; 2(2). PMID: 21415975    Free PMC article.
Lenograstim: a review of its use in chemotherapy-induced neutropenia, for acceleration of neutrophil recovery following haematopoietic stem cell transplantation and in peripheral blood stem cell mobilization.
Gillian M Keating.
Drugs, 2011 Apr 21; 71(6). PMID: 21504247
Review.
Personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy.
Nicole M Kuderer, Gary H Lyman.
J Natl Cancer Inst, 2011 Jun 15; 103(12). PMID: 21670422    Free PMC article.
Incidence of acute myeloid leukemia after breast cancer.
Caterina Giovanna Valentini, Luana Fianchi, +3 authors, Livio Pagano.
Mediterr J Hematol Infect Dis, 2012 Jan 06; 3(1). PMID: 22220266    Free PMC article.
Colony stimulating factors (CSF) biosimilars. Progress?
Florian Scotté, Vincent Launay-Vacher, Jean-Baptiste Rey.
Target Oncol, 2012 Jan 18; 7 Suppl 1. PMID: 22249656
Review.
Uptake and economic impact of first-cycle colony-stimulating factor use during adjuvant treatment of breast cancer.
Dawn L Hershman, Elizabeth T Wilde, +4 authors, Alfred I Neugut.
J Clin Oncol, 2012 Feb 09; 30(8). PMID: 22312106    Free PMC article.
A way forward on the medically appropriate use of white cell growth factors.
Thomas J Smith, Bruce E Hillner.
J Clin Oncol, 2012 Mar 01; 30(14). PMID: 22370327    Free PMC article.
Review.
Hematopoietic growth factors: personalization of risks and benefits.
Shannon Puhalla, Saveri Bhattacharya, Nancy E Davidson.
Mol Oncol, 2012 Apr 14; 6(2). PMID: 22497867    Free PMC article.
Review.
Pharmacoeconomics of the myeloid growth factors: a critical and systematic review.
Bradford R Hirsch, Gary H Lyman.
Pharmacoeconomics, 2012 May 01; 30(6). PMID: 22540394
Systematic Review.
Austrian Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) guideline for prophylaxis with granulocyte colony-stimulating factors (G-CSF) in gynecologic malignancies, including breast cancer.
Edgar Petru, Alain Gustave Zeimet, +9 authors, Austrian Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO).
Wien Klin Wochenschr, 2012 Jun 29; 124(11-12). PMID: 22739650
Trends in neutropenia-related inpatient events.
Chris M Kozma, Michael Dickson, +2 authors, Richard Barron.
J Oncol Pract, 2012 Sep 04; 8(3). PMID: 22942808    Free PMC article.
Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008.
Lindsay M Morton, Graça M Dores, +5 authors, Rochelle E Curtis.
Blood, 2013 Feb 16; 121(15). PMID: 23412096    Free PMC article.
Colony-stimulating factors for febrile neutropenia during cancer therapy.
Charles L Bennett, Benjamin Djulbegovic, LeAnn B Norris, James O Armitage.
N Engl J Med, 2013 Mar 22; 368(12). PMID: 23514290    Free PMC article.
Review.
Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.
Lois B Travis, Wendy Demark Wahnefried, +2 authors, Andrea K Ng.
Nat Rev Clin Oncol, 2013 Mar 27; 10(5). PMID: 23529000
Highly Cited. Review.
The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials.
G H Lyman, D C Dale, +5 authors, J Crawford.
Ann Oncol, 2013 Jun 22; 24(10). PMID: 23788754    Free PMC article.
Systematic Review.
Chemotherapy dosing in overweight and obese patients with cancer.
Gary H Lyman, Alex Sparreboom.
Nat Rev Clin Oncol, 2013 Jul 17; 10(8). PMID: 23856744
Review.
A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice.
S Barni, V Lorusso, +10 authors, P Pronzato.
Med Oncol, 2013 Dec 07; 31(1). PMID: 24307348
The evolving challenge of therapy-related myeloid neoplasms.
Jane E Churpek, Richard A Larson.
Best Pract Res Clin Haematol, 2014 Feb 11; 26(4). PMID: 24507808    Free PMC article.
Review.
Impact of granulocyte colony-stimulating factors in metastatic colorectal cancer patients.
A Amadio, R Burkes, +2 authors, B Coleman.
Curr Oncol, 2014 Feb 14; 21(1). PMID: 24523621    Free PMC article.
Biosimilar granulocyte-colony-stimulating factor for healthy donor stem cell mobilization: need we be afraid?
Halvard Bonig, Petra S Becker, Arnd Schwebig, Matthew Turner.
Transfusion, 2014 Jun 27; 55(2). PMID: 24965197    Free PMC article.
Review.
Myeloid toxicity of cancer treatment.
Sandra Kurtin.
J Adv Pract Oncol, 2012 Jul 01; 3(4). PMID: 25031949    Free PMC article.
Review.
Granulocyte colony-stimulating factors as prophylaxis against febrile neutropenia.
Sol Cortés de Miguel, Miguel Ángel Calleja-Hernández, Salomón Menjón-Beltrán, Inmaculada Vallejo-Rodríguez.
Support Care Cancer, 2014 Oct 07; 23(2). PMID: 25284722
Review.
Optimal management of breast cancer in the elderly patient: current perspectives.
Olivia Le Saux, Bertrand Ripamonti, +4 authors, Claire Falandry.
Clin Interv Aging, 2015 Jan 23; 10. PMID: 25609933    Free PMC article.
Review.
Impact of obesity on chemotherapy management and outcomes in women with gynecologic malignancies.
Neil S Horowitz, Alexi A Wright.
Gynecol Oncol, 2015 Apr 15; 138(1). PMID: 25870918    Free PMC article.
Review.
Effects of neutropenia and histological responses in esophageal squamous cell carcinoma with neo-adjuvant chemotherapy.
Hirotaka Konishi, Hitoshi Fujiwara, +6 authors, Eigo Otsuji.
Int J Clin Oncol, 2015 Jul 22; 21(1). PMID: 26194809
Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy.
Yasunori Hashiguchi, Mari Kasai, +3 authors, Toshiyuki Sumi.
Anticancer Drugs, 2015 Aug 13; 26(10). PMID: 26267078    Free PMC article.
Myelodysplastic syndrome and acute myeloid leukemia following adjuvant chemotherapy with and without granulocyte colony-stimulating factors for breast cancer.
Gregory S Calip, Judith A Malmgren, +2 authors, Henry G Kaplan.
Breast Cancer Res Treat, 2015 Oct 10; 154(1). PMID: 26450505    Free PMC article.
Prophylactic long-acting granulocyte-colony stimulating factors (G-CSF) in gynecologic malignancies: an oncologic expert statement.
Edgar Petru, Christian F Singer, +12 authors, Alain-Gustave Zeimet.
Wien Med Wochenschr, 2015 Oct 17; 165(19-20). PMID: 26471371
Review.
Results of a prospective dose intensity and neutropenia prophylaxis evaluation programme (DIEPP) in cancer patients at risk of febrile neutropenia due to myelosuppressive chemotherapy.
Radosław Mądry, Lidia Popławska, +10 authors, Christine Staudigl.
Wien Klin Wochenschr, 2016 Jan 10; 128(7-8). PMID: 26745973    Free PMC article.
Biosimilars in the management of neutropenia: focus on filgrastim.
Désirée Caselli, Simone Cesaro, Maurizio Aricò.
Biologics, 2016 Mar 05; 10. PMID: 26937170    Free PMC article.
Review.
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.
Thomas F Patterson, George R Thompson, +14 authors, John E Bennett.
Clin Infect Dis, 2016 Jul 02; 63(4). PMID: 27365388    Free PMC article.
Highly Cited.
Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.
Koichi Takahashi, Feng Wang, +17 authors, P Andrew Futreal.
Lancet Oncol, 2016 Dec 08; 18(1). PMID: 27923552    Free PMC article.
Highly Cited.
Transient CDK4/6 inhibition protects hematopoietic stem cells from chemotherapy-induced exhaustion.
Shenghui He, Patrick J Roberts, +10 authors, Norman E Sharpless.
Sci Transl Med, 2017 Apr 28; 9(387). PMID: 28446688    Free PMC article.
Myelodysplastic syndrome and acute myeloid leukemia after receipt of granulocyte colony-stimulating factors in older patients with non-Hodgkin lymphoma.
Gregory S Calip, Kellyn M Moran, +7 authors, Brian C-H Chiu.
Cancer, 2018 Dec 15; 125(7). PMID: 30548485    Free PMC article.
Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors.
Philip Riley, Anne-Marie Glenny, +4 authors, Martin G McCabe.
Cochrane Database Syst Rev, 2017 Nov 29; 11. PMID: 29181845    Free PMC article.
Systematic Review.
Maximizing Breast Cancer Therapy with Awareness of Potential Treatment-Related Blood Disorders.
Henry G Kaplan, Gregory S Calip, Judith A Malmgren.
Oncologist, 2020 Feb 20; 25(5). PMID: 32073195    Free PMC article.
Review.
Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study.
Ines Vaz-Luis, Romualdo Barroso-Sousa, +18 authors, Nancy U Lin.
J Clin Oncol, 2020 Apr 25; 38(21). PMID: 32330102    Free PMC article.
Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy.
Nicole Skoetz, Julia Bohlius, +3 authors, Jörg-Janne Vehreschild.
Cochrane Database Syst Rev, 2015 Dec 22; (12). PMID: 26687844    Free PMC article.
Systematic Review.
Eflapegrastim, a Long-Acting Granulocyte-Colony Stimulating Factor for the Management of Chemotherapy-Induced Neutropenia: Results of a Phase III Trial.
Lee S Schwartzberg, Gajanan Bhat, +9 authors, Patrick Wayne Cobb.
Oncologist, 2020 Jun 02; 25(8). PMID: 32476162    Free PMC article.
A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy-induced neutropenia in patients with early-stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study.
Patrick Wayne Cobb, Yong Wha Moon, +5 authors, Lee S Schwartzberg.
Cancer Med, 2020 Jul 21; 9(17). PMID: 32687266    Free PMC article.
Predicting neutropenia risk in patients with cancer using electronic data.
Pamala A Pawloski, Avis J Thomas, +3 authors, Gary H Lyman.
J Am Med Inform Assoc, 2016 Sep 18; 24(e1). PMID: 27638907    Free PMC article.
The Efficacy of Moxibustion for Breast Cancer Patients with Chemotherapy-Induced Myelosuppression during Adjuvant Chemotherapy: A Randomized Controlled Study.
Yajie Ji, Siyu Li, +12 authors, Xiaohong Xue.
Evid Based Complement Alternat Med, 2021 May 15; 2021. PMID: 33986813    Free PMC article.